Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Epidemiology and surveillance of Gram-negative infections caused by carbapenemase-producing organisms (CPOs) in the UKRelease Date:Research Internal Medicine United Kingdom Advancing Care for Patients with Advanced ALK+ Non-Small Cell Lung Cancer (NSCLC)Education Oncology All Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache DisordersQuality Improvement Internal Medicine Canada, USA Shared Decision Making in Hemophilia Patient CareRelease Date:Quality Improvement Rare Disease China Real-World Atopic Dermatitis: Italian Insights GrantRelease Date:Research Inflammation & Immunology Italy Evolving Treatment Options in First-Line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)Education Oncology All Optimizing Care for patients with Muscle Invasive Bladder Cancer (MIBC)Release Date:Quality Improvement Oncology Canada Optimizing HRRm Testing and Workflow Integration in mCSPCRelease Date:Quality Improvement, Research Oncology Canada Driving Timely Biomarker Testing to Optimize Treatment Decisions for Colorectal Cancer Patients Across CanadaRelease Date:Partner: Colorectal Cancer Canada (CCC)Quality Improvement, Research Oncology Canada Optimizing Disease Management to Improve Alopecia Areata Quality of CareRelease Date:Quality Improvement Inflammation & Immunology China Title Grant Type Focus Area Country Application Due Date Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Atopic DermatitisRelease Date:Education Inflammation & Immunology All Pharmacist Education in Biosimilars (Western Europe, Canada, Japan)Release Date:Education Oncology All Biosimilars in Hematologic Malignancies & Supportive CareRelease Date:Education Oncology All The Burden and Origins of Co-Infections in COVID-19 Pneumonia (Europe)Release Date:Education Hospital All Needs Assessment – Early Therapy Management with CDK 4/6 Inhibitors in Metastatic Breast CancerRelease Date:Education Oncology USA Advances in Atopic Dermatitis for Advanced PractitionersRelease Date:Education Inflammation & Immunology USA 2020 RD US- Next Generation PET Imaging for ATTR-CMResearch Rare Disease USA Cardiac Transthyretin Amyloid (ATTR) Fellowship Competitive Grant ProgramRelease Date:Partner: International Society of AmyloidosisFellowship Rare Disease All Management of Moderate-to-Severe Atopic Dermatitis for Dermatologists and AllergistsRelease Date:Education Inflammation & Immunology USA Pfizer and Mayo Clinic/Global Bridges–Providing Access to Learning Resources for Tobacco Dependence TreatmentEducation Internal Medicine China, Malaysia, Taiwan, Thailand 4th Quality Improvement initiatives optimizing AF and VTE management in CanadaQuality Improvement Internal Medicine Canada 2021 Rheumatology Competitive Grant ProgramRelease Date:Research Inflammation & Immunology USA